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The T cell immunoglobulin and mucin domain
(TIM) proteins are important regulators of T
cell responses. Crystal structures of the murine
TIM-4 identified a metal-ion-dependent ligand
binding site (MILIBS) in the immunoglobulin
(Ig) domain of the TIM family. The characteristic
CC0 loop of the TIM domain and the hydropho-
bic FG loop shaped a narrow cavity where
acidic compounds penetrate and coordinate
to a metal ion bound to conserved residues in
the TIM proteins. The structure of phosphatidyl-
serine bound to the Ig domain showed that the
hydrophilic head penetrates into the MILIBS
and coordinates with the metal ion, whereas
the aromatic residues on the tip of the FG loop
interacted with the fatty acid chains and could
insert into the lipid bilayer. Our results also re-
vealed an important role of the MILIBS in the
trafficking of TIM-1 to the cell surface.
INTRODUCTION
The TIM family is involved in the regulation of immune re-
sponses bymodulating effector Th1 and Th2 cell functions
(Kuchroo et al., 2006). Whereas TIM-1 and TIM-2 are
found in Th2 cells, TIM-3 is preferentially expressed in
Th1 cells. TIM-4 has been detected in antigen-presenting
cells andmay function as a natural ligand of TIM-1 (Meyers
et al., 2005). Crosslinking of murine TIM-1 (mTIM-1) on the
cell surface enhanced T cell activation and proliferation
(Meyers et al., 2005; Umetsu et al., 2005). Diverging
frommTIM-1, mTIM-2 inhibits Th2 responses (Chakravarti
et al., 2005; Rennert et al., 2006) and binds to heterolo-
gous ligands such as semaphorin 4A and ferritin H (Chen
et al., 2005; Kumanogoh et al., 2002). mTIM-3 provides
a negative costimulatory signal that leads to immune toler-
ance (Sabatos et al., 2003; Sanchez-Fueyo et al., 2003),
whereas binding of mTIM-3 to galectin-9 triggers Th1Imapoptosis and the inhibition of Th1 responses (Zhu et al.,
2005).
The TIM family has been associated with immune-re-
lated diseases, cancer, and viral infections. TIM-1 has
been usurped by the hepatitis A virus (HAV) for cell entry
in monkeys and humans (Feigelstock et al., 1998; Kaplan
et al., 1996). HAVCR1/TIM-1 is an important asthma-de-
terminant gene in humans (McIntire et al., 2003), and its
expression is upregulated in acute kidney diseases and
renal carcinoma (Han and Bonventre, 2004; Vila et al.,
2004). The TIM gene family is located in a genomic locus
linked to autoimmune diseases and asthma both inmouse
and humans (Kuchroo et al., 2006). These genes were
linked to an airway hyperreactivity regulatory locus, and
certain genetic variants of mTIM-1 and mTIM-3 were as-
sociated with the development of asthma in mouse
models (McIntire et al., 2001).
The TIM proteins are type I membrane proteins with an
N-terminal immunoglobulin (Ig) domain followed by a
heavily glycosylated mucin domain in the extracellular re-
gion, a single transmembrane region, and a cytoplasmic
tail with a tyrosine phosphorylation motif except in the hu-
man and mouse TIM-4, which have shorter cytoplasmic
regions and lack the membrane-distal tyrosine that be-
comes phosphorylated in other TIM proteins (Kuchroo
et al., 2006). Whereas sequence identity among the Ig do-
mains is high (40%–60%), there are large differences in
the length of the mucin domains (Kuchroo et al., 2003).
Crystal structures of the Ig domains of mTIM-1, mTIM-2,
and mTIM-3 revealed an Ig fold belonging to the V set
(Cao et al., 2007; Santiago et al., 2007). A folded CC0
loop disulphide linked to the GFC b sheet by four Cys res-
idues characteristic of the TIM proteins is a distinctive
structural feature of the IgV domain in the family. This
loop appeared structurally connected to the FG loop in
the mTIM-1 and mTIM-3 structures, building up a CC0FG
epitope onto the GFC b sheet (Cao et al., 2007; Santiago
et al., 2007). In contrast, in mTIM-2, the CC0 and FG loops
have a distinct conformation, so that the domain lacks the
structural epitope (Santiago et al., 2007). The structures
provided insights on ligand recognition by the TIM family.
The HAV virus and an unidentified mTIM-3 ligand appearmunity 27, 941–951, December 2007 ª2007 Elsevier Inc. 941
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A Ligand Binding Pocket in the TIM FamilyTable 1. Data Collection and Refinement Statistics
mTIM-4 (X1) mTIM-4 (X2) mTIM-4 (X3)
Data Processing
Space group P321 P6322 P6322
Cell dimensions
a, b, c (A˚) 65.3, 65.3, 57.0 67.8, 67.8, 129.1 66.3, 66.3, 139.4
a, b, g () 90, 90, 120 90, 90, 120 90, 90, 120
Wavelength 0.9310 0.9310 0.9793
Resolution (A˚) 25-2.95 25-2.2 25-2.5
Rsym or Rmerge 10.9 (27.2) 5.7 (21.1) 5.7 (16.8)
I/sI 6.7 (2.8) 10.5 (3.6) 9.3 (4.4)
Completeness (%) 98.3 (98.3) 99.9 (99.9) 99.9 (100)
Redundancy 5.2 (4.0) 20.2 (19.3) 11.0 (10.2)
Refinement
Resolution (A˚) 15-2.95 15-2.2 15-2.5
No. reflections 3036 9009 6421
Rwork/Rfree 23.6/26.8 21.8/23.8 21.9/24.8
No. atoms
Protein 893 864 855
Ligand/ion/water 12/0/11 10/1/80 26/1/47
B factors
Protein 27 25 36
Ligand/ion/water 12/-/18 16/15/29 45/34/38
Rms deviations
Bond lengths (A˚) 0.008 0.008 0.008
Bond angles () 1.763 1.110 1.114
Statistics of the three crystal structures (X1, X2, and X3) solved for the mTIM-4 IgV domain.
Diffaction data statistics at the highest resolution shell are shown in parentheses.
Ligands included were acetate (X1), tartrate (X2), or Dicaproyl-PS (X3). A sodium ion was modeled in the X2 and X3 structures.to bind to the GFC face of the IgV domain (Cao et al., 2007;
Santiago et al., 2007), whereas the opposite BED face was
used in intercellular interactions among receptors of the
TIM family (Santiago et al., 2007). Even though homophilic
TIM-1 binding and homotypic TIM-TIM receptor interac-
tions engaged the N-terminal IgV domains, high-affinity
binding of TIM-1 to either TIM-1 or TIM-4 required the
mucin domains (Meyers et al., 2005; Santiago et al.,
2007). It has been proposed that TIM-TIM receptor bind-
ing required a combinatorial epitope built by the IgV and
mucin domains (Wilker et al., 2007). Both domains were
also needed for efficient neutralization of HAV by soluble
monkey TIM-1 (Silberstein et al., 2003).
Crystal structures of the mTIM-4 IgV domain presented
here identified a distinctive ligand binding pocket with
a metal ion coordination site. The physiological ligand
phosphatidylserine (see accompanying paper from Ko-
bayashi et al., 2007, in this issue of Immunity) bound into
the cavity and coordinated to the metal. Mutation of pro-
tein residues engaged inmetal ion coordination or building942 Immunity 27, 941–951, December 2007 ª2007 Elsevier Inup the binding pocket in the IgV domain affected TIM
functions and showed the relevance of this site for ligand
recognition.
RESULTS
The Crystal Structure of the N-Terminal IgV
Domain of mTIM-4
The isolated N-terminal domain of mTIM-4 was obtained
essentially as described for the homologous mTIM-1
and mTIM-2 domains (Santiago et al., 2007). An initial
crystal form (X1) diffracting at about 3 A˚ resolution was
prepared with the crystallization conditions used for
mTIM-1 (Experimental Procedures and Table 1). The crys-
tal structure was solved by the molecular replacement
method (see Experimental Procedures). The IgV domain
had substantially longer b strands in the GFC than in the
BED b sheet (Figure 1A). The long CC0 loop folded back
onto the GFC b sheet as in the structures of the homolo-
gous TIM domains (Cao et al., 2007; Santiago et al.,c.
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A Ligand Binding Pocket in the TIM FamilyFigure 1. Crystal Structure of the N-Terminal Domain of mTIM-4 and Conformation of the CC0FG Loop Epitope
(A) Ribbon diagram of the mTIM-4 IgV domain structure (X1 in Table 1). b strands are labeled with uppercase letters whereas N- and C-terminal ends
are in lowercase. Cys residues and disulphide bonds are shown in green. The tip of the peculiar CC0 loop is shown in yellow with a ball-and-stick
representation and with the oxygens in red and the nitrogens in blue. The Arg and Lys residues bridging the tip of the CC0 loop to the F and G b strands
are orange. Hydrogen bonds are shown as shaded pink cylinders.
(B) Stereo view of the superimposed N-terminal IgV domains of mTIM-1 (red) and mTIM-4 (blue) structures crystallized under similar conditions. The
side chains of the conserved Phe and Asn residues having distinct conformation in the FG loop of the structures are included. BC, CC0, and FG loops
are labelled.
(C) Surface representation of the structures. CC0 and FG loops appeared connected inmTIM-1 (red), whereas they are disconnected inmTIM-4 (blue),
where a narrow cavity appears. Phe and Trp residues in the tip of the FG loop are labeled.2007). The bottom of the loop was bridged to the b sheet
by two disulphide bonds, whereas the tip was hydrogen
bonded to the conserved Arg and Lys residue on F and
G b strand, respectively (Figure 1A). The interactions of
the tip of the loop with the basic residues were also ob-
served in the mTIM-1 and mTIM-3 structures and they
were absent in mTIM-2 (Cao et al., 2007; Santiago et al.,
2007). Therefore, the conformation of the CC0 loop in the
mTIM-4 IgV domain structure was identical to that in
mTIM-1 (Figure 1B), whereas some structural variability
was observed in the BC and FG loops.
In the mTIM-1 structure, the CC0 and FG loops were
connected by a Phe residue that is conserved in the FG
loop of the mTIM-4 IgV domain (Figures 1B and 1C). Hy-
drophobic residues also joined the loops in the mTIM-3
domain (Cao et al., 2007). However, the loops appeared
disconnected in the mTIM-4 structure because of a con-
formational switch in the Phe side chain, which was
distant from the CC0 loop. The conformation of the Asn
residue conserved in the FG loop of the TIM proteins
was also switched (Figure 1B). A narrow cavity built by
the tip of the CC0 loop and the interacting basic residueImat the bottom and the aromatic Trp and Phe residues at
the top of the FG loopwas revealed by a surface represen-
tation of the mTIM-4 IgV domain structure (Figure 1C).
Some electron density was observed inside the cavity,
which could come from either an alternate conformation
of the Phe residue or a bound compound from the crystal-
lization buffer. Thus, the structure of the X1 crystal form of
mTIM-4 revealed a distinct conformation for the CC0FG
loop epitope from that shown by the mTIM-1 structure,
but the relevance of those changes was unclear.
AMetal Ion Coordination Site in the FG Loop of the
mTIM-4 IgV Domain
To get further insights on the conformation of the CC0FG
epitope in the TIM IgV domains from crystal structures,
we searched for new crystal forms with both the mTIM-1
and the mTIM-4 proteins. Crystals diffracting at 2.2 A˚ res-
olution were prepared with the mTIM-4 IgV domain and
with potassium sodium tartrate as precipitant (X2 in Table
1). The structure was almost identical to that of the X1
crystals (see Figure S1 available online). The Phe residue
on the FG loop pointed away from the CC0 loop, so thatmunity 27, 941–951, December 2007 ª2007 Elsevier Inc. 943
Immunity
A Ligand Binding Pocket in the TIM FamilyFigure 2. A Metal Ion Coordination Site in the FG Loop of the mTIM-4 IgV Domain
(A) Surface representation of the top region of the IgV domain structure determined in the presence of tartrate (X2 in Table 1). The tartrate inside of the
cavity built by the CC0 and FG loops is shownwith stick representation and with the carbons in yellow and the oxygens in red. The sodium ion to which
the tartrate coordinates is shown as a green sphere. In the protein, the oxygens are red, nitrogens blue, and carbons gray. Loops are labeled.
(B) Detailed view of the metal ion coordinated to the tartrate, to the main chain and side chain oxygens of FG loop residues, and to a water molecule
(red sphere). Electron Fo-Fc density map shown as a light blue mesh and contoured at 4s was determined omitting both tartrate and metal ion.
Coordinations are shown as dashed red lines, whereas hydrogen bonds are orange. Atoms are colored as in (A). The structure defined a metal-
ion-dependent ligand binding site (MILIBS).
(C) Structural alignment of the murine mTIM-1 (2OR8), mTIM-2 (2OR7), mTIM-3 (2OYP), and mTIM-4 IgV domain structures with residues closer than
3 A˚ aligned. b strands are shown with lines. The human and monkey (mk) TIM proteins were aligned by sequence. Conserved residues in most
domains are colored in yellow and the six Cys residues are in green. N-linked glycosylation sites are underlined and sequences of mTIM-1 and
mTIM-4 are numbered. Residues coordinating the cation in the mTIM-4 structure are red, while the aromatic residues at the tip of the FG loop building
the binding pocket are magenta. Labeled in (B).both loops were disconnected (Figure 2A). The high reso-
lution of the structure allowed the identification of an elec-
tron density filling up the cavity as a tartrate present at high
concentration in the crystallization conditions. The tartrate
lay below the Trp residue of the FG loop andwas hydrogen
bonded to several protein residues (Figure 2B). A second
electron density near the carboxylate group of the tartrate
was identified as a sodium or calcium metal ion by the
WaSP program (Nayal and Cera, 1996). The metal ion
was coordinated to the tartrate, to two main chain and
two side chain oxygens of an Asn and Asp residues in
the FG loop, and to a water molecule (Figure 2B). The co-
ordination number (6) and the average coordination dis-
tance (2.5 A˚) are usual for both sodium and calcium
ions, whereas the distances to potassium are more than
2.7 A˚ (Harding, 2002). A sodium ionwasmodeled because
of the lack of calcium in the crystallization conditions and
the lower B factor obtainedwith sodium in the structure re-
finement. Temperature B factor for potassium was similar
to that obtained with calcium (28) and higher than that of
the refined sodium ion (15), which was close to the tartrate
B factor (Table 1).
TheAsn andAspprotein residuesengaged inmetal coor-
dination are conserved in all TIM proteins except inmTIM-2
(highlighted in red in Figure 2C), which had distinct CC0 and944 Immunity 27, 941–951, December 2007 ª2007 Elsevier IncFG loops and therefore lacked the pocketwhere the tartrate
penetrates in themTIM-4 IgVdomain (Santiagoet al., 2007).
The high conservation of the residues involved in metal ion
coordination as well as the conserved conformation of the
CC0 loop suggested that this metal-ion-dependent ligand
binding site (MILIBS) will be conserved in the TIM family.
Coordination of the metal ion and ligand binding to the
pocket required an open conformation of the CC0FG loop
epitope,where both loopsmust bedisconnected (Figure 2).
No metal ions were identified by the WaSP program in the
mTIM-1 and mTIM-3 structures (PDB accession codes
2OR8and2OYP, respectively),where thecavitywasclosed
and the Asn residue at the FG loop was in a conformation
not suited for coordination of the metal ion (Figure 1B;
Cao et al., 2007; Santiago et al., 2007).
Binding of Phosphatidylserine to the MILIBS
TIM-1 and TIM-4 proteins bind to phosphatidylserine (PS)
exposed on the surface of apoptopic cells (Kobayashi
et al., 2007). We used X-ray crystallography to identify
the PS binding site in the IgV domain of murine TIM pro-
teins by cocrystallization of the isolated N-terminal do-
main of mTIM-4 with a PS compound having a short fatty
acid moiety (C6). The structure of the complex was deter-
mined at 2.5 A˚ resolution (X3 in Table 1)..
Immunity
A Ligand Binding Pocket in the TIM FamilyFigure 3. Structure of the mTIM-4 IgV Domain with a Bound Phosphatidylserine Ligand
(A) Surface representation of the top region of the IgV domain structure (X3 in Table 1) with a bound Dicaproyl-PS and the sodium ion to which it
coordinates (green sphere). The PS is shown with carbons in yellow, phosphate in orange, oxygens in red, and nitrogens in blue.
(B) Detailed view of the MILIBS and the interactions of the bound PS with the metal ion and with mTIM-4 amino acid residues. Electron Fo-Fc density
map shown as a light bluemesh and contoured at 3swas determined omitting both the PS and themetal ion. Coordinations are shown as dashed red
lines, whereas hydrogen bonds are orange. Interacting residues are labeled. The protein atoms are shown as in Figure 2.The structure revealed that the PS ligand bound to the
MILIBS (Figure 3), with its hydrophilic moiety penetrating
in the cavity built by the CC0 and FG loops. The acidic
phosphate group of PS coordinated with the metal ion
that was linked to the same mTIM-4 residues and with
the same average coordination distance (2.5 A˚) seen in
the mTIM-4 structure with tartrate (Figure 3B). The bipyra-
midal metal ion coordination was consistent with the pres-
ence of either a sodium or calcium ion according to the
WaSP program (Nayal and Cera, 1996), although the tem-
perature B factor was lower for sodium (34) than for cal-
cium (58). A sodium ion was included in the final PDB be-
cause of the lower B factor and Rfree values given by the
structure refinement, even though calcium was included
in the preparation of the mTIM-4-PS complex at low con-
centration. The structure of the metal ion coordination
site is similar to that seen in a PS annexin-V complex,
where thephosphatecoordinateswithacalcium ionbound
mostly tomain chain oxygens of a protein loop and the car-
boxylate of a glutamic acid residue (Swairjo et al., 1995).
The Ser residue of PS fitted between the metal ion and
the tip of the CC0 loop (Figure 3). Its amine group made
specific interactions with the conserved Asp residue
involved in metal ion coordination (Figure 3B), whereas
the carboxylate of the Ser was hydrogen bonded with
a main chain amino and the hydroxyl group of a Ser resi-
due in the CC0 loop of the mTIM-4 IgV domain. These
interactions were specific for the L stereoisomer of PS
used in the crystallization. In the D isomer, the amino
and carboxylate groups of the Ser will interchange their
positions, so that the carboxylate faces a repulsive elec-
trostatic environment. The size of the phosphate-linked
Ser and its interactions with the protein appear to be
unique for PS, and they are likely responsible for the
restricted phospholipid binding specificity of the TIM pro-
teins (Kobayashi et al., 2007). The fatty acid moiety thatImanchors the phospholipid to the lipid bilayer interacts
with the hydrophobic side chains of the Trp and Tyr resi-
dues in the FG loop (Figure 3), so that they must penetrate
into the lipid bilayer upon TIM binding to PS on the surface
of apoptotic cells (Kobayashi et al., 2007). Residues on the
BC loop such as the Arg found in mTIM-1 and mTIM-4 will
be close to the membrane (Figure 3A), and they could in-
teract with the lipid bilayer as well. The BC loop is largely
variable among IgV domains of the TIM family (Figure 2C)
and bears mTIM-3 polymorphic residues (McIntire et al.,
2001). This loop could regulate the PS binding affinity of
the TIM proteins. Residue variation in either BC, CC0, or
FG loops could provide specificity to phospholipid binding
by the TIM proteins. Even though TIM-3 conserves the
residues involved in metal ion coordination (ND), it does
not have any aromatic residue in the FG loop (Figure 2C),
which are critical for binding of mTIM-1 and mTIM-4 to PS
(see below).
Binding of Murine TIM Proteins to PS
and Contribution of the MILIBS
mTIM-1 and mTIM-4 soluble proteins bound to liposomes
containing PS, whereas no binding was observed with
mTIM-2 (Figure 4A). The TIMproteins did not bind to phos-
phatidylcholine in liposomes (not shown). mTIM-1 and
mTIM-4 shared high sequence similarity in the FG and
CC0 loops that build the MILIBS and bound similarly to
PS, which is indicative of a nearly identical binding
mode. Soluble TIM molecules having the isolated IgV
domain bound to PS liposomes, whereas no binding
was detected with themucin domain alone (Figure S2; Ko-
bayashi et al., 2007). However, it appears that the mucin
domain facilitated binding of the bivalent mTIM soluble
molecules to PS liposomes and could be important for
presentation of the IgV domain on the cell surface.munity 27, 941–951, December 2007 ª2007 Elsevier Inc. 945
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A Ligand Binding Pocket in the TIM FamilyFigure 4. Binding of Murine TIM Proteins to PS in Liposomes
and Contribution of the MILIBS
(A) Binding of murine TIM proteins to PS in liposomes. Optical density
(O.D.) at 492 nm monitoring binding of soluble Fc fusion proteins with
the complete extracellular region to liposomes immobilized on plastic
(see Experimental Procedures). Mean ± SD of three experiments is
shown.
(B) Normalized binding of mTIM-1 (dark) and mTIM-4 (white) wild-type
and mutant proteins to PS in liposomes. Mutations to Ala included res-
idues involved in metal ion coordination (N/A, ND/AA) or building the
MILIBS cavity (W/A, F/A, WF/AA) (Figures 2 and 3). Binding of the
mutant Fc fusion proteins were normalized to the wild-type protein
binding. Untested mutant is marked with an asterisk. Mean + SD of
three experiments where the binding ratio was determined with several
protein concentrations (20 to 1 mg/ml) is shown.
(C) Competitors of TIM binding to PS. Binding of mTIM-1 and mTIM-4
Fc fusion proteins at 20 mg/ml to plastic-bound liposomes was deter-
mined in the absence or the presence of the indicated compound as in
(A): Dicaproyl-PS (DCPS, circles), EDTA (squares), tartrate (triangles),
and NaCl (cross). Binding ratios were determined from the O.D. mea-
sured at the indicated inhibitor concentration, and those determined in
the absence of inhibitor in three independent experiments for either
mTIM-1 or mTIM-4. The concentration of the inhibitory compounds
is shown in the x axis. Mean ± SD of the ratios determined with the
mTIM-1 and mTIM-4 proteins are shown. IC50 are in parentheses.946 Immunity 27, 941–951, December 2007 ª2007 Elsevier IncThe single (N/A) and double (ND/AA) mutation of the
metal ion coordination residues decreased significantly
(85%) and similarly binding of mTIM-1 and mTIM-4 pro-
teins to PS in liposomes (Figure 4B), suggesting that
both residues shared metal ion coordination required for
PS binding (Figure 3B). However, single Ala substitutions
of the aromatic residues in the FG loop (W/A or F/A)
decreased about 70% binding of the TIM proteins to PS
in liposomes, whereas the double mutation had an addi-
tive effect and abolished binding (Figure 4B). The dramatic
effect of theWF/AA substitution indicated that the FG loop
aromatic residues provided most of the binding energy. In
good correlation with these results, Ala substitution of
MILIBS residues inhibited also TIM-4 binding to PS on
apoptotic cells and subsequent cellular phagocytosis of
eryptotic red blood cells (Kobayashi et al., 2007).
Binding of the mTIM-1 and mTIM-4 proteins to PS lipo-
somes was inhibited with the dicaproyl PS compound
used for crystallization (Figure 4C). The inhibition observed
at low concentration of EDTA (Figure 4C) or EGTA (not
shown) indicated requirement of divalent calcium ions for
high-affinity binding. However, purifiedmTIM-1-Fc protein
bound toPS liposomeswithout addition of divalent cations
(not shown), and the structure of the mTIM-4-PS complex
showed that the most likely metal ion coordinated at the
MILIBS was sodium (Table 1). Therefore, we can not ex-
clude that the chelating agents blocked binding by pene-
trating into the binding pocket rather than by chelating
divalent ions. The observed inhibitory effect of tartrate
was consistent with the binding of this compound to the
MILIBS (Figure 2), whereas the moderate inhibitory effect
observed at high concentrations of sodium chloride must
be electrostatic (Figure 4C). Binding of the TIM proteins
to PS was blocked also by TIM antibodies (not shown).
These results proved a highly conserved PS recognition
mode in themTIM-1 andmTIM-4 proteins, consistent with
the high similarity of the PS binding pocket revealed by the
structure (Figures 2C and 3). Moreover, this binding mode
is likely to be shared by human TIM-1 and TIM-4, which
have identical PS binding residues at the FG loop com-
pared to the mouse proteins (Figure 2C) and bound to
the phospholipid with similar affinities (Kobayashi et al.,
2007).
TheMILIBS Regulates the Trafficking ofmTIM-1 to
the Cell Surface
Recently we reported that most of the mTIM-1 protein
(C57BL/6J strain variant) expressed in transfected lym-
phocytes was intracellular and that efficient trafficking of
mTIM-1 to the cell surface required stimulation with phor-
bol esters or ionomycin (Santiago et al., 2007). To deter-
mine the role of the MILIBS in the trafficking of mTIM-1
to the cell surface, we analyzed the cellular distribution
of fluorescent-tagged mTIM-1 protein mutants by confo-
cal microscopy (Figure 5A). Most of the wild-type protein
accumulated in intracellular vesicles, such as reported
earlier (Santiago et al., 2007). However, we observed
that the mutants lacking either the cation binding (N/A or
ND/AA) or the aromatic residues (WF/AA) at the FG loop.
Immunity
A Ligand Binding Pocket in the TIM Familywere well expressed on the cell surface, such as we ob-
served with the mTIM-2 protein (Santiago et al., 2007).
These results showed that the MILIBS had a marked influ-
ence on the cellular distribution of mTIM-1, regulating the
trafficking of mTIM-1 to the cell surface.
Figure 5. Regulation ofmTIM-1 Trafficking to theCell Surface
by the MILIBS
(A) Fluorescence of isolated 300.19 preB cells transfected with wild-
type and mutant mTIM-1 proteins tagged with a cyan fluorescent
protein (CFP) at their C-terminal ends are shown in the first row. Super-
imposed fluorescence and DIC confocal images are shown in the
second row. The mutant proteins had Ala substitutions in the metal
ion coordination residues (N/A andND/AA) or in the residues on the up-
per lip (WF/AA) of the MILIBS (Figures 2 and 3). Representative images
of three different experiments.
(B) Analysis of cell-surface expression of wild-type andmutant mTIM-1
proteins and presentation of antibody epitopes. Flow cytometry of
300.19 cells transfected with the proteins indicated on the top of the
figure tagged with a yellow fluorescent protein (YFP). Confocal images
of transfected cells with the YFP-tagged proteins are shown in
Figure S3. Histograms on the top show the percentage of transfected
cells (yellow), whereas the overlay histograms on the bottom show the
detection of the cell-surface-expressed Ab epitopes. Detection was
carried out with the T1.4 or T1.10 mTIM-1 Ab and a PE (red)-conju-
gated secondary antibody. Curves correspond to 300.19 cells untrans-
fected (gray) or transfected with the wild-type (red) or the indicated
mutant proteins. The percentage of YFP-positive cells expressing
the Ab epitopes on the cell surface (% cell) and the mean fluorescence
(mean) are shown below the histograms.ImWe analyzed the cell-surface presentation of two dis-
tinct IgV domain antibody epitopes (T1.4 and T1.10) map-
ped onto the IgV domain of wild-type and mutant mTIM-1
soluble proteins (not shown). The antibodies recognized
cell-surface-expressed mutant proteins (Figure 5B). How-
ever, we observed that the T1.10 epitope in the wild-type
protein was greatly diminished with respect to the T1.4
epitope and was detected in just 11% of the transfected
300.19 pre-B cells. In transfected 293T cells, the T1.10
epitope was displayed in about 30% of the cells present-
ing the T1.4 epitope (not shown). The lower mean fluores-
cence of the T1.4 antibody on the wild-type compared to
the mutant mTIM-1-transfected cells showed lower
amount (about 20%) of wild-type mTIM-1 molecules on
the cell surface, as also shown by the confocal micros-
copy (Figure 5A). The differential display of IgV epitopes
in the wild-type and the mutant mTIM-1 proteins on the
cell surface indicated two distinct conformations for the
membrane-bound mTIM-1.
Models for TIM Binding to PS and the Regulation
of mTIM-1 Trafficking to the Cell Surface
The structure of the mTIM-4 IgV domain with a bound PS
and the functional data on the contribution of MILIBS res-
idues to the interaction led to the proposal of a model for
binding of the TIM-1 and TIM-4 IgV domains to mem-
brane-bound PS (Figure 6). The critical contribution of
the aromatic residues on the upper lip of the MILIBS to
the binding interaction (Figure 4B) and its proximity to the
fatty acid moiety of PS (Figure 3) suggested the insertion
of the hydrophobic tip of the FG loop into the lipid
bilayer upon penetration of the phospholipid hydrophilic
head into the binding pocket. The neighboring BC and
CC0 loops are likely to interact also with the membrane
(Figure 6). The interaction of the top region of the IgV do-
main with the membrane could generate some distortion
on the lipid bilayer. This binding model must be shared
by the human andmouse TIM-1 and TIM-4 proteins, which
bear the same aromatic residues in the tip of the FG loop.
Nevertheless, the diversity in the BC andCC0 loops among
the TIM proteins (Figure 2C) suggests slight differences on
their binding interactions with membrane-bound PS.
The increase in the concentration of intracellular cal-
cium related to cell activation induces the appearance of
PS on the outer leaflet of the cell membrane (Bratton
et al., 1997; Williamson et al., 1992; Zwaal and Schroit,
1997) and mediates the efficient trafficking of mTIM-1 to
the cell surface (Santiago et al., 2007). This correlation in
the cellular distribution of mTIM-1 and its physiological li-
gand PS as well as the cell-surface localization of mTIM-1
mutants with a disrupted PS binding suggested that the
observed mTIM-1 intracellular accumulation could be
dependent on its PS-binding activity. After translocation
and folding in the luminal side of the endoplasmic reticu-
lum (ER), type I membrane proteins are linked to the ER
membrane by both the N-terminal signal peptide and the
transmembrane region. The proximity of the MILIBS to
the ER membrane prior to the proteolysis of the signal
peptide could allow binding to PS, which would link themunity 27, 941–951, December 2007 ª2007 Elsevier Inc. 947
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A Ligand Binding Pocket in the TIM FamilyFigure 6. Model for TIM Protein Binding to PS and the Regulation of mTIM-1 Trafficking to the Cell Surface
The picture shows a model for a TIM IgV domain (ribbon representation with b strands in red and pink) interacting with a membrane-bound PS
molecule based on the structure presented in Figure 3. The interaction model shows the Trp and Phe residues (magenta) in the tip of the FG loop
penetrating into the lipid bilayer (yellow), whereas the phosphate of PS (shown as in Figure 3) coordinates to themetal ion (green sphere) in the binding
pocket. The adjacent CC0 and BC loops come close to the membrane contributing to the interaction. This bindingmodemust be representative of the
human and mouse TIM-1 and TIM-4 proteins, which bind to PS and bear aromatic residues in the FG loop (Figures 2C and 4; Kobayashi et al., 2007).
Inside: Representation of anmTIM-1 protein (mucin domain in green) after folding and cleavage of the signal peptide andwith the IgV domain bound to
PS and the lipid bilayer through the MILIBS. This conformation represents the intracellular protein seen in resting lymphocytes (mTIM-1 in Figure 5A).
Outside: Increasing the intracellular calcium concentration upon cellular activation alters the membrane lipid asymmetry (Zwaal and Schroit, 1997) so
that the PS-bound mTIM-1 protein flops toward the outer leaflet of the cell membrane (left), where the IgV domain dissociates from the PS (right).
Folded and extended molecules may be present on the cell surface.tip of the IgV domain to the lipid bilayer (Figure 6). So the
N-terminal IgV domain of mTIM-1 could remain bound to
the membrane after cleavage of the signal peptide in the
ER and the protein would then be sequestered inside
the cells. It is known that increasing the intracellular cal-
cium concentration induces transbilayer diffusion ofmem-
brane-bound phospholipids (flip-flop) and the exposure of
PS on the outer leaflet of the cell surface by the activation
of the nonspecific lipid scramblase (Verhoven et al., 1995;
Williamson et al., 1992; Zwaal and Schroit, 1997). There-
fore, an increase in the intracellular calcium concentration
could enhance the exposure of PS-bound TIM proteins to
the outer leaflet of themembrane upon cell activation, with
subsequent release of the IgV domain from the phospho-
lipid on the cell surface by extracellular factors or by com-
petition with ligands (Figure 6). This model implies the
presence of two distinct conformations for the mTIM-1
molecule on the cell surface, supported by the distinct
presentation of the T1.10 IgV domain epitope in the wild-
type and mutant proteins (Figure 5B).
DISCUSSION
The structures of the mTIM-4 IgV domain identified
a metal-ion-dependent ligand binding site (MILIBS) used
for binding to phosphatidylserine by the TIM proteins.948 Immunity 27, 941–951, December 2007 ª2007 Elsevier IncThe ligand binding specificity is mediated by both the con-
strained size of the cavity and the requirement for an
acidic group in the ligand for coordination with the metal
ion. Although the most likely ion seen in the structures is
sodium, other cations with similar coordination behavior
such as calcium could bind to this site depending on the
ligand. The narrow cavity where the PS penetrates is built
by two distinctive loops in the IgV domains of TIM pro-
teins, so that the MILIBS is a specific signature of this
receptor family. The lack of a ligand binding pocket in
mTIM-2 resulting from its distinct CC0 loop and the ab-
sence of cation coordination residues in its FG loop further
prove a divergent ligand recognition mode for this TIM
family member (Santiago et al., 2007).
Comparison of the ligand-free mTIM-1 with the mTIM-4
structure in complex with PS showed certain require-
ments for residue rearrangement on the CC0FG loop epi-
tope for ligand binding. In the open conformation of the
MILIBS revealed by the mTIM-4 structure, the hydropho-
bic Phe and Trp residues on the tip of the loop were
primed for penetration into the lipid bilayer upon binding
to PS on the cell surface. The hydrophobic tip of the FG
loop in TIM-1 and TIM-4 resembles fusion loops described
in class II virus membrane proteins (Harrison, 2005), which
are known to penetrate into cellular membranes. The in-
teraction of the hydrophobic residues with the cell.
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the TIMproteins to PS, whereas themetal ion coordination
and the interactions of the Ser residue with the protein
must provide the phospholipid binding specificity. Even
though the metal ion coordination residues and the con-
formation of the CC0 loop are conserved in all TIM but
mTIM-2, there are certain differences in the FG and CC0
loops building up the binding pocket. These differences
could have a substantial influence on the binding affinity.
Additional interaction of the IgV domain with the mem-
brane could be mediated by residues at the tip of the BC
loop, such as the Arg residues found in mTIM-1 and
mTIM-4 or the residues that defined a polymorphism in
the mTIM-3 BC loop (McIntire et al., 2001). The interaction
model presented here for TIM binding to PS in cellular
membranes is analogous to that proposed for binding of
annexin-V and protein kinase C (Swairjo et al., 1995;
Verdaguer et al., 1999). In those models, hydrophobic
residues near the PS binding site penetrated into the
membrane, and residues on neighboring protein loops,
such as a Lys in protein kinase C, defined a second inter-
acting site with the bilayer.
Because the expression of TIM-4 is restricted to phago-
cytic cells, including macrophages and dendritic cells, the
binding of PS to TIM-4 suggests that a major function of
TIM-4 is the recognition and removal of apoptotic cells
by such phagocytic cells (Kobayashi et al., 2007). Indeed,
TIM-4-expressing cells rapidly and specifically phagocy-
tized apoptotic cells, and this process was prevented by
TIM-4 Ab and mutations in the MILIBS residues. In con-
trast, because expression of TIM-1 is restricted to T cells
and to ischemic kidney cells, the binding of TIM-1 to PS
may mediate resolution of ischemic kidney damage by
clearance of dying renal tubular epithelial cells and may
regulate TIM-1 intracellular trafficking in T cells.
The ability of mTIM-1 to bind phospholipids, its intracel-
lular accumulation, and the absence of the T1.10 antibody
epitope in the membrane-bound wild-type protein led us
to propose two distinct conformations for the protein on
the cell surface that could be shared by TIM proteins bind-
ing to PS: one folded molecule with the tip of the IgV
domain penetrating into the lipid bilayer and a second
extended conformation where the IgV domain would be
available for ligand binding on the cell surface. Moreover,
TIM binding to PS on its own membrane could sequester
the proteins inside of the cell, where PS resides, prevent-
ing their exposure on the cell surface for ligand binding
and subsequent TIM-mediated intracellular signaling. Ac-
cording to this model, the efficient trafficking of the mTIM-
1 protein to the cell surface observed upon cell activation
could be related to either its intracellular release from PS
or to the flopping of the PS-bound TIM toward the outer
leaflet of the cell membrane by changes in the lipid mem-
brane polarity. It is well documented that the increase of
the intracellular concentration of calcium during cell acti-
vation flops PS out of the cell membrane by the simulta-
neous activation of the enzyme scramblase and the inhibi-
tion of the aminophospholipid-specific translocase (Zwaal
and Schroit, 1997). This regulatory mechanism formTIM-1trafficking appears to be specific for TIM proteins that bind
PS and might differ from other regulatory processes such
as that described for CTLA-4 (Linsley et al., 1996).
According to the trafficking regulatory model presented
here, the exposure of a functional mTIM-1 and perhaps
other TIM proteins for ligand binding would be controlled
and restricted to certain cellular conditions. Uncontrolled
exposure of TIM molecules on the cell surface could
come from changes in the IgV domain affecting its intra-
cellular interaction with PS and the lipid bilayer, such as
those seen here with the MILIBS mutants. The length of
the variable mucin domain in the TIM proteins could deter-
mine also the ability of the IgV domain to bind membrane-
bound PS in the ER lumen, so that the trafficking of the
proteins to the cell surface could vary among TIM family
members. Polymorphisms in mTIM-1 (McIntire et al.,
2001), whichmodify the signal peptide and extend themu-
cin domain in the BALBc strain variant, could increase the
distance between the tip of the IgV domain and the lipid
bilayer prior to the cleavage of the signal peptide, prevent-
ing binding to PS and facilitating the trafficking of the TIM
molecules to the cell surface. This uncontrolled exposure
of certain TIM proteins could trigger undesired intracellu-
lar signals leading to lymphocyte activation upon binding
to exogenous ligands.
We have shown here a unique metal-ion-dependent
ligand binding site in the Ig domain of TIM proteins built
up by distinctive structural motifs specifically found in
the N-terminal domains of this family. We showed that
this is a phosphatidylserine binding site and that it could
be also involved in recognition of an identified mTIM-3
ligand and HAV, whose binding surface has been map-
ped on the GFC face of the IgV domain where the MILIBS
locates (Cao et al., 2007; Santiago et al., 2007). Prelimi-
nary observations indicated the involvement of the
MILIBS in TIM-TIM interactions as well. Small molecules
containing acidic groups could bind also to the MILIBS,
whereas binding to multimeric ligands might crosslink
TIM proteins on the cell surface and trigger intracellular
signals. The critical contribution of the MILIBS to TIM
functions and its concave and well-defined size opens
up the rational design of small molecules targeting this
site and modulating the functions of the TIM family in
the immune system.
EXPERIMENTAL PROCEDURES
Antibodies and cDNAs
mTIM-1 monoclonal antibodies (T1.4 and T1.10) and a mTIM-4 poly-
clonal antibody used were from eBioscience, Inc. The full-length
cDNAs coding for mTIM-1 and mTIM-4 were from the mouse strain
C57BL/6J strain and were used as templates for preparation of all
the constructs.
Protein Sample Preparation
The mTIM-4 IgV domain was prepared by in vitro refolding of inclusion
bodies produced in bacteria as described elsewhere (Santiago et al.,
2007). The domain had an N-terminal Met residue, residues 43 to
154 of the precursor mTIM-4 protein, a thrombin recognition site,
and two epitope tags. The soluble protein eluted from a Superdex-
75 column (Amersham Biosciences) with a retention volume aroundImmunity 27, 941–951, December 2007 ª2007 Elsevier Inc. 949
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A Ligand Binding Pocket in the TIM Family15–20 kDa. The recombinant proteins were thrombin treated to release
C-terminal tags and further purified by ion-exchange chromatography
with 25 mM HEPES buffer (pH 7.5).
mTIM-4 Crystallization and Structure Determination
Small crystals of the mTIM-4 domain diffracting at about 3 A˚ were ini-
tially prepared (crystal form X1, Table 1) at a protein concentration of
15 mg/ml and crystallization conditions having 30% PEG-2000 meth-
ylether, 5% PEG-400, 0.1 M ammonium sulfate, 0.1 M sodium acetate
(pH 5.6), and 100 mM O-(n-Octyl)-phosphorylcholine. The X1 crystals
belong to the hexagonal P321 space group, they have one molecule in
the asymmetric unit and 55% solvent content. A second crystal form
(X2) diffracting at 2.2 A˚ resolution was prepared with purified protein
at 10mg/ml and 0.8 M potassium sodium tartrate having 0.1 MHEPES
(pH 7.5) (Table 1). The crystals have one molecule in the asymmetric
unit, 63% of solvent content, and they belong to the hexagonal
P6322 space group (Table 1). Complexes of the TIM-4 IgV domain
and PS were prepared by incubation of the protein (15 mg/ml) with
5 mM 1,2-Dicaproyl-sn-Glycero-3-(Phospho-L-Serine) (Dicaproyl-
PS, Avanti) in 25 mM HEPES buffer (pH 7.0) with 5 mM CaCl2 and
100mMNaCl. The complex was crystallized at a protein concentration
of 15 mg/ml and conditions having 10% Jeffamine, 10 mM FeCl3, and
0.1M sodium citrate (pH 5.6). The crystals (form X3) have onemolecule
in the asymmetric unit, 64% of solvent content, and belong to the
hexagonal P6322 space group (Table 1). Diffraction data were col-
lected with frozen crystals.
The structures of the mTIM-4 IgV domain were determined by the
molecular replacement method with the program Phaser (Read,
2001) and the mTIM-2 structure (2OR7) lacking BC, CC0, and FG loops
as search model. The X1 crystal form was refined with the program
CNS (Bru¨nger et al., 1998), whereas the structure of the X2 and X3
crystal formswere refinedwith Refmac (CCP4, 1994).Models were ad-
justed manually during the refinement process. The first two N-termi-
nal and the last four C-terminal residues were poorly defined in the
electron density maps. All residues in the structures are in allowed
regions of Ramachandran plots. The ribbon representations were pre-
pared with the program ribbons (Carson, 1987), whereas the remaining
figures of the structures were done with PYMOL (http://www.pymol.
org).
Protein Expression in Mammalian Cells
DNAs coding for the indicated fragment of the proteins and having the
human IgG1-Fc region (TIM-Fc) at the C terminus were prepared by
transient expression in 293T cells, and protein concentration was
determined by ELISA (Santiago et al., 2007). Recombinant constructs
for expression of isolated mucin domains included the IgK leader
sequence from the pDisplay vector (Invitrogen) at their 50 end. Muta-
genesis was done by the overlapping PCR technique and confirmed
by DNA sequencing. All mutants bound to the specific TIM antibodies
as the wild-type soluble proteins in ELISA tests.
Fluorescent-tagged proteins at their cytoplasmic tails were ex-
pressed on the surface of 293T or 300.19 pre-B cells by transfection
with recombinant TIM cDNAs cloned in-frame with a cyan or yellow
fluorescent variant of GFP (CFP or YFP) in the pECFP-N1 or pEYFP-
N1 vectors (Clontech), respectively. Expression was analyzed on
a D-Eclipse C1 Leika microscope 1 day after transfection with a
435/10 nm and 500/20 nm excitation filter, 455 nm and 515 nmdichroic
beam splitter, and a 480/20 nm and 535/30 emission filter, respec-
tively, for CFP and YFP.
Binding of TIM Proteins to Phospholipids in Liposomes
Mixturesofphosphatidylserine:cholesterol (4:1)orphosphatidylcholine:
cholesterol (4:1) (Sigma-Aldrich) were resuspended in chloroform:
methanol (3:1, v/v). The solvent was removed with a rotary evaporator
and finally dried under vacuum. PS and PC liposomes were resus-
pended in PBS to a final phospholipid concentration of 100 mM and
sonicated to clarity. Binding of soluble Fc fusion proteins prepared in
mammalian cells to plastic-coated liposomes was carried out in dupli-950 Immunity 27, 941–951, December 2007 ª2007 Elsevier Inccate wells of 96-well plates. Binding of liposomes to the plastic was
done by adding 50 ml of the suspension at 0.01 mM to the wells and
incubated overnight at 4C. Cell supernatants containing soluble Fc fu-
sion proteins were diluted with DMEM (Invitrogen) having 5% FCS at
the indicated protein concentration, and binding assays were carried
out essentially as performed for TIM-TIM protein binding (Santiago
et al., 2007). Background binding signal to wells lacking liposomes
was subtracted from optical density determined in wells with lipo-
somes.
Supplemental Data
Three figures are available at http://www.immunity.com/cgi/content/
full/27/6/941/DC1/.
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